Ellzey & Associates, PLLC IS ACTIVELY REVIEWING CLAIMS against the manufacturers of EzriCare Eye Drops for eye infections, brain infections, blindness, death, and other injuries
The eyedrops were recalled in early February after the Centers for Disease Control and Prevention linked them to an outbreak of Pseudomonas aeruginosa. This is a rare, extensively drug resistant, and deadly bacteria that has contaminated the EZRICARE ARTIFICIAL TEARS line of EzriCare Eyedrops products. EzriCare recalled the products in February 2023.
As of March 23, 2023, the CDC reports that three people have died from the infection and approximately 68 others across 16 states have reported infections.
Officials were able to trace the current outbreak to the use of over 10 different brands of eyedrops, but noted that the most commonly reported brand used was EzriCare Artificial Tears, which is a preservative free eye-lubricant.
II. Potential Responsible Parties and Products
- Global Pharma Healthcare Private LTD. (India-based manufacturer)
- EzriCare, LLC (New Jersey-based U.S. distributor)
- EZriRx, LLC (Delaware-based U.S. distributor)
- Aru Pharma, Inc. (New York-based U.S. distributor)
- Delsam Pharma’s NDC 72570-121-15, UPC-72570-0121-15
- EzriCare NDC 79503-0101-15, UPC 3 79503 10115 7
III. Symptoms to Watch
See a doctor if you are experiencing the following symptoms:
- Blurred vision.
- Conjunctivitis, also called pink eye.
- Discharge from the eye.
- Endophthalmitis, also called inflammation within the eye.
- Keratitis, also called inflammation of the cornea.
- Pain or discomfort in the eye.
- Sensitivity to light.
- Brain damage.
- Organ failure.
- Tissue damage.
CALL US TODAY FOR A FREE EVALUATION: +1 888-350-3931
EMAIL US TODAY AT FIRM@ELLZEYLAW.COM
Confidential & Secure
Privately submit your case information. Our team of legal experts will be in touch to schedule a time to discuss your case more in detail.